India to resume vaccine exports to poor countries in Covax programme
Announcement comes ahead of Prime Minister Narendra Modi’s visit to the US
20 September 2021 - 21:45
byNeha Arora and Krishna N Das
Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
New Delhi — India will resume exports of Covid-19 vaccines from the next quarter, prioritising the global vaccine-sharing platform Covax and neighbouring countries first as supplies rise, the health minister said on Monday.
India, the world’s biggest maker of vaccines, stopped exports of vaccines in April to focus on inoculating its own population as infections exploded. The Serum Institute of India (SII) had been due to deliver more than a billion doses in 2021.
The country’s monthly vaccine output has since more than doubled and is set to quadruple to more than 300-million doses in October, minister Mansukh Mandaviya said, adding that only excess supplies would be exported.
“We will help other countries and also fulfil our responsibility towards Covax,” he said.
India had donated or sold 66-million doses to nearly 100 countries before the exports were halted.
The announcement on resumption of exports to poor countries comes ahead of Prime Minister Narendra Modi’s visit to Washington this week where vaccines are likely to be discussed at a summit of the leaders from the US, India, Japan and Australia.
India wants to vaccinate all its 944-million adults by December and has so far given at least one dose to 64% of them and two doses to 22%.
India’s inoculations have jumped since August, especially as the SII has more than trebled its output of the AstraZeneca shot to 200-million doses a month from April’s output.
Indian companies have set up the capacity to produce nearly 3 -billion vaccine doses a year.
Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
India to resume vaccine exports to poor countries in Covax programme
Announcement comes ahead of Prime Minister Narendra Modi’s visit to the US
New Delhi — India will resume exports of Covid-19 vaccines from the next quarter, prioritising the global vaccine-sharing platform Covax and neighbouring countries first as supplies rise, the health minister said on Monday.
India, the world’s biggest maker of vaccines, stopped exports of vaccines in April to focus on inoculating its own population as infections exploded. The Serum Institute of India (SII) had been due to deliver more than a billion doses in 2021.
The country’s monthly vaccine output has since more than doubled and is set to quadruple to more than 300-million doses in October, minister Mansukh Mandaviya said, adding that only excess supplies would be exported.
“We will help other countries and also fulfil our responsibility towards Covax,” he said.
India had donated or sold 66-million doses to nearly 100 countries before the exports were halted.
The announcement on resumption of exports to poor countries comes ahead of Prime Minister Narendra Modi’s visit to Washington this week where vaccines are likely to be discussed at a summit of the leaders from the US, India, Japan and Australia.
India wants to vaccinate all its 944-million adults by December and has so far given at least one dose to 64% of them and two doses to 22%.
India’s inoculations have jumped since August, especially as the SII has more than trebled its output of the AstraZeneca shot to 200-million doses a month from April’s output.
Indian companies have set up the capacity to produce nearly 3 -billion vaccine doses a year.
Reuters
Covax slashes vaccine delivery target
SA targets improved vaccine coverage for adults before offering jabs to children
Local elections will not affect vaccination drive, says deputy health minister
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Most Read
Published by Arena Holdings and distributed with the Financial Mail on the last Thursday of every month except December and January.